BSE · 543444
Fabino Enterprises Limited
Revenue & net profit by period
Bars = revenue (₹ Cr) · line = net profit (₹ Cr). Straight from disclosed results.
Latest period: revenue ₹18 Cr with net profit ₹0 Cr — a 0.33% net margin, versus 0.17% the period before.
Shareholding
As of 2026-03-31
- Promoter56.82%
- Public43.18%
141 shareholders on record
Promoter holding trend
Each disclosed period, oldest to newest
52-week position
Where the current price sits in its yearly band
The band spans 2.08× from low to high.
Risk flags
Derived from disclosed data
- Under exchange surveillance — GSM · GSM 0 · ESM · ESM 1. Trading may carry price bands, periodic call auction or higher margins.
Peer comparison
Pharmaceuticals - Indian - Bulk Drugs & Formln · ranked #93 of 102 by market cap · medians across 50 industry peers
| Company | Mkt cap | P/E | P/B | ROE | Margin |
|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | ₹4,77,444 Cr | 38.42 | 5.71 | 13.74% | 19.72% |
| Cipla Ltd. | ₹1,19,101 Cr | 214.6 | 3.46 | 11.27% | 12.06% |
| Zydus Lifesciences Ltd. | ₹1,11,990 Cr | 20.62 | 4.13 | 18.59% | 18.86% |
| Lupin Limited | ₹1,11,885 Cr | 70.26 | 4.98 | 23.76% | 19.4% |
| Mankind Pharma Limited | ₹1,07,077 Cr | 192.91 | 6.57 | 11.74% | 13.4% |
| Laurus Labs Limited | ₹96,235 Cr | 344.55 | 18.14 | 16.77% | 13.05% |
| Dr Reddys Laboratories Ltd. | ₹95,345 Cr | 431.06 | 2.51 | 11.07% | 9.73% |
| Aurobindo Pharma Ltd. | ₹92,388 Cr | 100.3 | 2.44 | 9.25% | 10.5% |
| Biocon Ltd. | ₹70,215 Cr | 545.38 | 2.04 | 1.14% | 2.3% |
| Alkem Laboratories Ltd. | ₹67,823 Cr | 286.92 | 4.91 | 16.66% | 15.65% |
| Fabino Enterprises Limited(this company) | ₹4 Cr | — | 1.09 | -9.15% | 0% |
AI analysis
AI-generated · google/gemini-2.5-flashFabino Enterprises Limited (543444) has a market capitalization of Rs 4 Cr. The company reported a negative return on equity (ROE) of -9.15% and a negative return on capital employed (ROCE) of -6.91%. The debt-to-equity ratio is 0.37.
Positives
- +Promoter holding is 56.82% as of Mar 2026, indicating significant control.
- +No shares have been pledged by the promoters.
- +EPS increased to Rs 0.29 in Mar 2025 from Rs 0.17 in Mar 2024.
Negatives
- −The company reported a negative return on equity (ROE) of -9.15%.
- −The return on capital employed (ROCE) is negative at -6.91%.
- −The profit margin is 0%.
- −The company is under surveillance measures (GSM, ESM).
- −No quarterly results have been disclosed since Jun 2021.
Financial Performance
The company's revenue increased to Rs 18.33 Cr in Mar 2025 from Rs 2.11 Cr in Mar 2024. Net profit grew to Rs 0.06 Cr in Mar 2025 from Rs 0.04 Cr in Mar 2024. Earnings per share (EPS) also rose to Rs 0.29 in Mar 2025 from Rs 0.17 in Mar 2024.
Profitability & Returns
Fabino Enterprises Limited reported a negative return on equity (ROE) of -9.15% and a negative return on capital employed (ROCE) of -6.91%. The overall profit margin for the company is 0%. The earnings per share (EPS) for the latest available period is Rs 0.
Balance Sheet
The debt-to-equity ratio for the company stands at 0.37. The book value per share is Rs 18.71. There is no dividend yield reported for the company.
Ownership & Pledges
Public shareholding is 43.18%. There is no promoter shareholding pledged. The number of shareholders as of Mar 2026 is 141.
Regulatory & Surveillance
Fabino Enterprises Limited is under surveillance measures, specifically GSM and ESM. The current surveillance label is "GSM · GSM 0 · ESM · ESM 1".
Data as of — price: 2026-07-30 · financials: Mar 25 · shareholding: Mar 26. Figures are restated only when the company files again, so a period shown here is the most recent one on record — not necessarily the current quarter.
How this is produced: every figure above is computed from exchange filings and financial data mirrored by IPO Plus — no figure is generated or estimated. This is a factual summary for information and education only. It is not investment advice, not a recommendation to buy, sell or hold any security, and contains no price targets. Verify against the company's filings and the exchanges before any decision.
Back to Fabino Enterprises Limitedshare price & fundamentals